These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30717997)

  • 1. Efficacy of secukinumab in psoriasis and psoriatic arthritis: A retrospective multicentre study.
    Ruiz-Villaverde R; Rodriguez-Fernandez-Freire L; Galán-Gutierrez M; Martinez-Pilar L
    Med Clin (Barc); 2020 May; 154(9):370-371. PubMed ID: 30717997
    [No Abstract]   [Full Text] [Related]  

  • 2. Paradoxical Pustular Psoriasis in a Patient With Psoriatic Arthritis on Secukinumab Treatment.
    Abbruzzese A; Venerito V; Lopalco G; Fornaro M; Giannotta M; Iannone F
    J Clin Rheumatol; 2020 Sep; 26(6):e208-e209. PubMed ID: 31192857
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful secukinumab treatment of erythrodermic psoriasis and psoriatic arthritis concomitant with severe noninfectious uveitis: a case report.
    Lu J; Tang S; Yu N; Yi X; Li Y
    J Int Med Res; 2020 Nov; 48(11):300060520969494. PubMed ID: 33161790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secukinumab retreatment associated psoriasis flare with pustules.
    El-Komy M; Amer M; Mostafa A; ElKalioby M
    J Dermatolog Treat; 2022 Mar; 33(2):1107-1110. PubMed ID: 32538223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis.
    Cai L; Zhang JZ; Zheng M; Zhang SF; Patekar M
    Chin Med J (Engl); 2021 Sep; 134(21):2629-2631. PubMed ID: 34748527
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of secukinumab in a pediatric patient leads to significant improvement in nail psoriasis and psoriatic arthritis.
    Wells LE; Evans T; Hilton R; Wine Lee L; Ruth N
    Pediatr Dermatol; 2019 May; 36(3):384-385. PubMed ID: 30811618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis.
    van de Kerkhof PCM
    Br J Dermatol; 2021 Nov; 185(5):879. PubMed ID: 34402525
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term efficacy and safety of secukinumab in the treatment of the multiple manifestations of psoriatic disease.
    Reich K; Warren RB; Coates LC; Di Comite G
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1161-1173. PubMed ID: 31785165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secukinumab in the Treatment of Psoriasis and Psoriatic Arthritis: A Review of the Literature.
    Abrouk M; Gandy J; Nakamura M; Lee K; Brodsky M; Singh R; Zhu H; Farahnik B; Bhutani T; Koo J
    Skin Therapy Lett; 2017 Jul; 22(4):1-6. PubMed ID: 28732152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of twins affected by psoriasis, psoriatic arthritis and autism: Five years of efficacious and safe treatment with Secukinumab.
    Bernardini N; Skroza N; Marraffa F; Prevete E; Mambrin A; Proietti I; Tolino E; Caviglia M; Di Guardo A; Rossi G; Volpe S; Bersani G; Potenza C
    Dermatol Ther; 2022 Jul; 35(7):e15533. PubMed ID: 35460156
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and effectiveness of secukinumab in psoriasis vulgaris and psoriatic arthritis: Real-world evidence in Japan.
    Fujita H; Ohtsuki M; Morita A; Nagao R; Seko N; Matsumoto K; Tani Y; Terui T
    J Dermatol; 2021 Feb; 48(2):175-183. PubMed ID: 33099791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data.
    Deodhar A; Mease PJ; McInnes IB; Baraliakos X; Reich K; Blauvelt A; Leonardi C; Porter B; Das Gupta A; Widmer A; Pricop L; Fox T
    Arthritis Res Ther; 2019 May; 21(1):111. PubMed ID: 31046809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adalimumab for the treatment of severe psoriasis and psoriatic arthritis.
    Papoutsaki M; Costanzo A; Chimenti MS; Chimenti S
    Expert Opin Biol Ther; 2008 Mar; 8(3):363-70. PubMed ID: 18294106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secukinumab (AIN-457) for the treatment of Psoriasis.
    Jaleel T; Elmets C; Weinkle A; Kassira S; Elewski B
    Expert Rev Clin Pharmacol; 2016; 9(2):187-202. PubMed ID: 26647300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach.
    Gordon KB; Ruderman EM
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S85-91. PubMed ID: 16488334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of secukinumab in patients with psoriasis, psoriatic arthritis, and ankylosing spondylitis.
    Conesa-Nicolás E; García-Lagunar MH; Núñez-Bracamonte S; García-Simón MS; Mira-Sirvent MC
    Farm Hosp; 2020 Dec; 45(1):16-21. PubMed ID: 33443473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of psoriatic arthritis with secukinumab: a case series.
    Nicola S; Rolla G; Monti R; Brussino L
    J Dermatolog Treat; 2018; 29(sup1):6-8. PubMed ID: 30247936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-IL-17 Medications Used in the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review.
    Canavan TN; Elmets CA; Cantrell WL; Evans JM; Elewski BE
    Am J Clin Dermatol; 2016 Feb; 17(1):33-47. PubMed ID: 26649440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secukinumab: A Review in Psoriatic Arthritis.
    Shirley M; Scott LJ
    Drugs; 2016 Jul; 76(11):1135-45. PubMed ID: 27299434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adalimumab for treatment of moderate to severe psoriasis and psoriatic arthritis.
    Bongiorno MR; Pistone G; Doukaki S; Aricò M
    Dermatol Ther; 2008 Oct; 21 Suppl 2():S15-20. PubMed ID: 18837728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.